ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,194, issued on Nov. 4, was assigned to Hansa Biopharma AB (Lund, Sweden).
"Cysteine protease" was invented by Emma Andersson Nordahl (Lund, Sweden), Christian Kjellman (Lund, Sweden), Kaisa Karhumaa (Lund, Sweden), Karl Markus Roupe (Lund, Sweden), Robert Bockermann (Lund, Sweden) and Sofia Jarnum (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG and in v...